RAAPID Raises Series A Investment to Expand Neuro-Symbolic AI Platform
RAAPID leverages cutting-edge Neuro-symbolic AI to improve risk adjustment accuracy and optimize healthcare operations.
Company Name: RAAPID
Location: Louisville, KY
Industry: Healthcare AI
Funding Details:
Amount: Undisclosed (Series A)
Investor: M12 (Microsoft’s Venture Fund)
Purpose of Investment:
The funds will be used to expand RAAPID’s Neuro-symbolic AI platform, enhancing its capabilities and impact in the healthcare sector.
Leadership:
CEO and Founder: Chetan Parikh
Product:
RAAPID provides a cloud-based risk adjustment platform tailored for healthcare payers, providers, and supporting organizations. Key features include:
- Chronic Condition Identification: AI-powered analysis to detect and document chronic health conditions.
- HCC Code Determination: Automates the assignment of Hierarchical Condition Category (HCC) codes.
- Risk Score Calculation: Streamlines risk adjustment processes for value-based care.
- Population Health Trends Analysis: Leverages data insights to optimize healthcare outcomes.
Target Audience:
RAAPID serves organizations participating in:
- Medicare Advantage
- ACA (Affordable Care Act)
- Medicare ACO (Accountable Care Organizations)
- Medicaid Programs
About the Company:
RAAPID leverages cutting-edge Neuro-symbolic AI to improve risk adjustment accuracy and optimize healthcare operations. Its innovative platform supports healthcare organizations in enhancing care delivery and ensuring compliance with regulatory standards.
With its Series A funding from M12, RAAPID is poised to scale its platform and continue advancing AI solutions that transform healthcare risk management.
